Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Cost-effectiveness analysis

Cost-effectiveness of stem cell therapy versus standard of care for acute and subacute ischemic stroke

Soichiro Takamiya, Yasuhiro Morii, Toshiya Osanai, Kazuki Ohashi, Katsuhiko Ogasawara, Kiyohiro Houkin, Miki Fujimura

published 21 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Spinal mechanisms and feasibility of Dry Needling versus Botulinum Toxin Type A in post-stroke lower limb spasticity: A proof-of-concept randomized clinical trial protocol (STROKE-POC)

Clara Pujol-Fuentes, Bart Eeckhaut, Samuel Fernández Carnero, Daniel Fernández Sanchís, Theodore Wein, Pablo Herrero, Wim Saeys, Mindy F. Levin

published 20 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma

XueYin Xu, Lian Tang, XiangHua Piao, ShaoQing Zhan, Yong Chen, PanFeng Feng

published 14 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective

Chaohao Shi, Yang Wang, Chongqing Tan, Xiaohui Zeng, Qiao Liu

published 13 May 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Costs and cost-effectiveness of the Safer Births Bundle of Care intervention in Tanzania health facilities

Boniphace Marwa, Corinna Vossius, Jan Terje Kvaløy, Benjamin Kamala, Pascal Mdoe, Hege Langli Ersdal, Frida N Ngalesoni, Albino Kalolo, Domenica Morona

published 28 Apr 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of biofire assay for respiratory infection testing: An economic evaluation exploring the inclusion of the costs of antimirobial resistance

Raymond Oppong, Raj Gill, Kay Roy

published 27 Apr 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country

Thang Xuan Do, Ha Thi Nguyen, Phuong Thi Lan Nguyen, Mai Thi Tuyet Kieu, Tuan Viet Duong, Van Nu Hanh Pham

published 03 Apr 2026

Loading metrics information...

Metrics unavailable. Please check back later.

HiMSC and EV derived treatments increase Quality of Life and reduce amount of Knee Replacement Surgeries compared to current standard of care for knee osteoarthritis patients in The Netherlands

Iris W. A. Boot, Georgina Shaw, Yolande F. M. Ramos, Mary Murphy, Ingrid Meulenbelt, Hubertus J. M. Vrijhoef, on behalf of the AutoCRAT consortium

published 26 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-utility and budget impact analyses of significant fibrosis detection in individuals with metabolic syndrome or obesity in Thailand

Chayanis Kositamongkol, Pichaya Tantiyavarong, Alissa Ratanatawan, Pimsiri Sripongpun, Prawej Mahawithitwong, Prawat Kositamongkol, Surasak Saokaew, Pochamana Phisalprapa

published 23 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Comparative analysis of the impact of chickenpox and herpes zoster vaccination in Belgium under two different exogenous boosting mechanisms

James Wambua, John C. Lang, Benson Ogunjimi, Niel Hens, Philippe Beutels

published 19 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Cost-effectiveness of percutaneous patent foramen ovale closure versus medical therapy for cryptogenic stroke prevention: A Chinese healthcare perspective

Chen Chen, Ting Xu, Zhujun Zeng, Jing Miao, Rong Hu, Yiming Gao, Chunlin Li, Meng Li, Xiaoli Yang

published 17 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

A cost-effective breast cancer screening strategy for Urban China: Findings from a Shenzhen-based modeling study

Changqing Tu, Yuke Zhong, Huan Li, Haifeng Qi, Qian Lu, Xuesen He

published 12 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to present

Chukwuka Elendu

published 11 Mar 2026

Loading metrics information...

Metrics unavailable. Please check back later.

Advertisement

Create a weekly email alert for: Cost-effectiveness analysis

You can change these options by clicking profile then "Alerts and Notifications"